| Dr Timothy S Grange, MD | |
|
4052 Pioneer Pkwy, Suite 208, Salt Lake City, UT 84120-2062 | |
| (801) 955-1232 | |
| (801) 955-1543 |
| Full Name | Dr Timothy S Grange |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 37 Years |
| Location | 4052 Pioneer Pkwy, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932169430 | NPI | - | NPPES |
| 891801521205 | Other | UT | UTAH STATE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 891801521205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverton Hospital | Riverton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comprehensive Medical Management, Pc | 0042242786 | 2 |
News Archive
"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).
Biofilms-mats of bacteria similar to the plaque that grows on teeth-frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can threaten lives or lead to failure of the implants. Antibiotics are impotent against biofilms.
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
Fueling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the U.S. House of Representatives by Rep. Mike Doyle (D-PA) and a bi-partisan host of co-sponsors.
› Verified 3 days ago
| Entity Name | Comprehensive Medical Management, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104060714 PECOS PAC ID: 0042242786 Enrollment ID: O20090723000403 |
News Archive
"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).
Biofilms-mats of bacteria similar to the plaque that grows on teeth-frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can threaten lives or lead to failure of the implants. Antibiotics are impotent against biofilms.
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
Fueling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the U.S. House of Representatives by Rep. Mike Doyle (D-PA) and a bi-partisan host of co-sponsors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy S Grange, MD 4052 Pioneer Pkwy, Suite 208, Salt Lake City, UT 84120-2062 Ph: (801) 955-1232 | Dr Timothy S Grange, MD 4052 Pioneer Pkwy, Suite 208, Salt Lake City, UT 84120-2062 Ph: (801) 955-1232 |
News Archive
"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).
Biofilms-mats of bacteria similar to the plaque that grows on teeth-frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can threaten lives or lead to failure of the implants. Antibiotics are impotent against biofilms.
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
Fueling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the U.S. House of Representatives by Rep. Mike Doyle (D-PA) and a bi-partisan host of co-sponsors.
› Verified 3 days ago
James Tran, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: Rehab 85 N Medical Drive Rm 2122, Salt Lake City, UT 84132 Phone: 801-585-2589 | |
Dr. Chase K Hansen, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1121 E Brickyard Rd Apt 1803, Salt Lake City, UT 84106 Phone: 801-309-0848 | |
Michael Tobler, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6360 S 3000 E Ste 300, Salt Lake City, UT 84121 Phone: 385-900-5094 | |
Dr. Jeffrey G Randle, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1160 E 3900 S, #5000, Salt Lake City, UT 84124 Phone: 801-262-8486 Fax: 801-284-8699 | |
Dr. Michael Matthew Green, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 81 N Mario Capecchi Dr, Department Of Pediatrics, Salt Lake City, UT 84113 Phone: 801-213-7737 Fax: 801-587-7539 | |
Ms. Allison Oki, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Univerisity Of Utah, Department Of Pm&r, Salt Lake City, UT 84132 Phone: 801-585-2589 Fax: 801-587-7287 | |
Bradeigh Smithson Godfrey, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 258 Heritage Ctr, Salt Lake City, UT 84112 Phone: 801-587-1290 |